1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kohda, D. Inagaki, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 31 11928 11939 10.1021/bi00162a036 1445923 Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. 1992 US Biochemistry BICHAW 0033 0006-2960 31 677 Structure of Epidermal Growth Factor Bound to Perdeuterated Dodecylphosphocholine Micelles Determined by Two-Dimensional NMR and Simulated Annealing Calculations 1992 US Biochemistry BICHAW 0033 0006-2960 30 4896 Characterization of Ph Titration Shifts for All the Nonlabile Proton Resonances in a Protein by Two-Dimensional NMR: The Case of Mouse Epidermal Growth Factor 1991 JA J.Biochem.(Tokyo) JOBIAO 0418 0021-924X 103 741 Tertiary Structure of Mouse Epidermal Growth Factor Determined by Two-Dimensional 1H NMR 1988 AT Biochem.Int. BIINDF 0758 0158-5231 16 647 A Comparative 1H NMR Study of Mouse Alpha(1-53) and Beta(2-53) Epidermal Growth Factors 1988 JA J.Biochem.(Tokyo) JOBIAO 0418 0021-924X 103 554 Complete Sequence-Specific 1H Nuclear Magnetic Resonance Assignments for Mouse Epidermal Growth Factor 1988 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6050.717 EPIDERMAL GROWTH FACTOR 1 man polymer no no NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus sample 10090 Mus musculus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1992-03-24 REL REL 10 BRUNGER refinement X-PLOR ASN 1 n 1 ASN 1 A SER 2 n 2 SER 2 A TYR 3 n 3 TYR 3 A PRO 4 n 4 PRO 4 A GLY 5 n 5 GLY 5 A CYS 6 n 6 CYS 6 A PRO 7 n 7 PRO 7 A SER 8 n 8 SER 8 A SER 9 n 9 SER 9 A TYR 10 n 10 TYR 10 A ASP 11 n 11 ASP 11 A GLY 12 n 12 GLY 12 A TYR 13 n 13 TYR 13 A CYS 14 n 14 CYS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A GLY 17 n 17 GLY 17 A GLY 18 n 18 GLY 18 A VAL 19 n 19 VAL 19 A CYS 20 n 20 CYS 20 A MET 21 n 21 MET 21 A HIS 22 n 22 HIS 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A LEU 26 n 26 LEU 26 A ASP 27 n 27 ASP 27 A SER 28 n 28 SER 28 A TYR 29 n 29 TYR 29 A THR 30 n 30 THR 30 A CYS 31 n 31 CYS 31 A ASN 32 n 32 ASN 32 A CYS 33 n 33 CYS 33 A VAL 34 n 34 VAL 34 A ILE 35 n 35 ILE 35 A GLY 36 n 36 GLY 36 A TYR 37 n 37 TYR 37 A SER 38 n 38 SER 38 A GLY 39 n 39 GLY 39 A ASP 40 n 40 ASP 40 A ARG 41 n 41 ARG 41 A CYS 42 n 42 CYS 42 A GLN 43 n 43 GLN 43 A THR 44 n 44 THR 44 A ARG 45 n 45 ARG 45 A ASP 46 n 46 ASP 46 A LEU 47 n 47 LEU 47 A ARG 48 n 48 ARG 48 A TRP 49 n 49 TRP 49 A TRP 50 n 50 TRP 50 A GLU 51 n 51 GLU 51 A LEU 52 n 52 LEU 52 A ARG 53 n 53 ARG 53 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 3 A N TYR 3 A O HIS 22 A O HIS 22 A N MET 21 A N MET 21 A O THR 30 A O THR 30 A N SER 38 A N SER 38 A O THR 44 A O THR 44 2 A A HD21 H ASN SER 1 2 1.25 3 A A HH HE1 TYR TRP 37 49 1.22 6 A A H1 H ASN SER 1 2 1.29 1 A TYR 37 0.081 SIDE CHAIN 1 A ARG 41 0.314 SIDE CHAIN 1 A ARG 45 0.307 SIDE CHAIN 1 A ARG 48 0.310 SIDE CHAIN 1 A ARG 53 0.189 SIDE CHAIN 2 A ARG 41 0.311 SIDE CHAIN 2 A ARG 45 0.205 SIDE CHAIN 3 A TYR 37 0.095 SIDE CHAIN 3 A ARG 41 0.311 SIDE CHAIN 3 A ARG 45 0.271 SIDE CHAIN 3 A ARG 48 0.244 SIDE CHAIN 3 A ARG 53 0.319 SIDE CHAIN 4 A TYR 37 0.092 SIDE CHAIN 4 A ARG 41 0.316 SIDE CHAIN 4 A ARG 45 0.099 SIDE CHAIN 4 A ARG 48 0.290 SIDE CHAIN 4 A ARG 53 0.176 SIDE CHAIN 5 A TYR 10 0.067 SIDE CHAIN 5 A TYR 37 0.077 SIDE CHAIN 5 A ARG 41 0.315 SIDE CHAIN 5 A ARG 45 0.276 SIDE CHAIN 5 A ARG 48 0.267 SIDE CHAIN 5 A ARG 53 0.125 SIDE CHAIN 6 A TYR 37 0.075 SIDE CHAIN 6 A ARG 41 0.298 SIDE CHAIN 6 A ARG 45 0.077 SIDE CHAIN 6 A ARG 48 0.267 SIDE CHAIN 6 A ARG 53 0.318 SIDE CHAIN 7 A TYR 10 0.079 SIDE CHAIN 7 A TYR 37 0.096 SIDE CHAIN 7 A ARG 41 0.172 SIDE CHAIN 7 A ARG 45 0.190 SIDE CHAIN 7 A ARG 48 0.217 SIDE CHAIN 7 A ARG 53 0.318 SIDE CHAIN 8 A TYR 37 0.083 SIDE CHAIN 8 A ARG 41 0.286 SIDE CHAIN 8 A ARG 45 0.322 SIDE CHAIN 8 A ARG 48 0.315 SIDE CHAIN 8 A ARG 53 0.232 SIDE CHAIN 9 A TYR 37 0.084 SIDE CHAIN 9 A ARG 41 0.269 SIDE CHAIN 9 A ARG 45 0.262 SIDE CHAIN 9 A ARG 48 0.265 SIDE CHAIN 9 A ARG 53 0.300 SIDE CHAIN 10 A TYR 37 0.070 SIDE CHAIN 10 A ARG 41 0.297 SIDE CHAIN 10 A ARG 45 0.314 SIDE CHAIN 10 A ARG 48 0.189 SIDE CHAIN 1 5.64 0.90 109.00 114.64 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 1 -6.91 1.00 110.10 103.19 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 1 6.53 0.90 109.00 115.53 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 1 7.79 1.10 130.40 138.19 A A A NE1 CE2 CZ2 TRP TRP TRP 50 50 50 N 1 -6.17 1.00 107.30 101.13 A A A NE1 CE2 CD2 TRP TRP TRP 50 50 50 N 2 -8.18 1.30 127.00 118.82 A A A CB CG CD1 TRP TRP TRP 49 49 49 N 2 6.04 0.90 109.00 115.04 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 2 -6.51 1.00 110.10 103.59 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 2 6.22 0.90 109.00 115.22 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 2 7.95 1.10 130.40 138.35 A A A NE1 CE2 CZ2 TRP TRP TRP 50 50 50 N 2 -6.08 1.00 107.30 101.22 A A A NE1 CE2 CD2 TRP TRP TRP 50 50 50 N 3 -7.88 1.30 127.00 119.12 A A A CB CG CD1 TRP TRP TRP 49 49 49 N 3 5.88 0.90 109.00 114.88 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 3 -6.60 1.00 110.10 103.50 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 3 6.12 0.90 109.00 115.12 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 3 7.58 1.10 130.40 137.98 A A A NE1 CE2 CZ2 TRP TRP TRP 50 50 50 N 4 -6.44 1.00 110.10 103.66 A A A CG CD1 NE1 TRP TRP TRP 49 49 49 N 4 6.42 0.90 109.00 115.42 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 4 6.68 1.10 130.40 137.08 A A A NE1 CE2 CZ2 TRP TRP TRP 49 49 49 N 4 -6.21 1.00 110.10 103.89 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 4 6.28 0.90 109.00 115.28 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 5 -6.57 1.00 110.10 103.53 A A A CG CD1 NE1 TRP TRP TRP 49 49 49 N 5 6.42 0.90 109.00 115.42 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 5 7.34 1.10 130.40 137.74 A A A NE1 CE2 CZ2 TRP TRP TRP 49 49 49 N 5 -6.43 1.00 110.10 103.67 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 5 6.36 0.90 109.00 115.36 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 6 -10.49 1.30 127.00 116.51 A A A CB CG CD1 TRP TRP TRP 49 49 49 N 6 5.82 0.90 109.00 114.82 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 6 -6.74 1.00 110.10 103.36 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 6 5.84 0.90 109.00 114.84 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 7 -8.29 1.30 127.00 118.71 A A A CB CG CD1 TRP TRP TRP 49 49 49 N 7 5.77 0.90 109.00 114.77 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 7 -6.83 1.00 110.10 103.27 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 7 6.20 0.90 109.00 115.20 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 7 7.33 1.10 130.40 137.73 A A A NE1 CE2 CZ2 TRP TRP TRP 50 50 50 N 8 6.06 0.90 109.00 115.06 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 8 7.20 1.10 130.40 137.60 A A A NE1 CE2 CZ2 TRP TRP TRP 49 49 49 N 8 -7.05 1.00 110.10 103.05 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 8 6.49 0.90 109.00 115.49 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 9 -7.91 1.30 127.00 119.09 A A A CB CG CD1 TRP TRP TRP 49 49 49 N 9 5.66 0.90 109.00 114.66 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 9 -6.92 1.00 110.10 103.18 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 9 6.47 0.90 109.00 115.47 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 10 -6.64 1.00 110.10 103.46 A A A CG CD1 NE1 TRP TRP TRP 49 49 49 N 10 6.46 0.90 109.00 115.46 A A A CD1 NE1 CE2 TRP TRP TRP 49 49 49 N 10 7.07 1.10 130.40 137.47 A A A NE1 CE2 CZ2 TRP TRP TRP 49 49 49 N 10 -6.40 1.00 110.10 103.70 A A A CG CD1 NE1 TRP TRP TRP 50 50 50 N 10 6.46 0.90 109.00 115.46 A A A CD1 NE1 CE2 TRP TRP TRP 50 50 50 N 1 A A CG ND1 HIS HIS 22 22 -0.105 0.015 1.369 1.264 N 1 A A CG CD2 TRP TRP 50 50 -0.103 0.017 1.432 1.329 N 2 A A CG ND1 HIS HIS 22 22 -0.105 0.015 1.369 1.264 N 3 A A CG ND1 HIS HIS 22 22 -0.104 0.015 1.369 1.265 N 3 A A CG CD2 TRP TRP 50 50 -0.103 0.017 1.432 1.329 N 4 A A CG ND1 HIS HIS 22 22 -0.103 0.015 1.369 1.266 N 4 A A CG CD2 TRP TRP 49 49 -0.105 0.017 1.432 1.327 N 5 A A CG ND1 HIS HIS 22 22 -0.102 0.015 1.369 1.267 N 5 A A CG CD2 TRP TRP 49 49 -0.104 0.017 1.432 1.328 N 6 A A CG ND1 HIS HIS 22 22 -0.101 0.015 1.369 1.268 N 7 A A CG ND1 HIS HIS 22 22 -0.103 0.015 1.369 1.266 N 7 A A CG CD2 TRP TRP 50 50 -0.103 0.017 1.432 1.329 N 8 A A CG ND1 HIS HIS 22 22 -0.106 0.015 1.369 1.263 N 9 A A CG ND1 HIS HIS 22 22 -0.104 0.015 1.369 1.265 N 10 A A CG ND1 HIS HIS 22 22 -0.105 0.015 1.369 1.264 N 10 A A CG CD2 TRP TRP 49 49 -0.105 0.017 1.432 1.327 N 1 A SER 2 70.27 -18.90 1 A TYR 3 42.13 95.54 1 A PRO 7 -36.67 115.78 1 A SER 9 -47.10 -17.56 1 A TYR 10 -84.34 -78.49 1 A ASP 11 27.25 37.97 1 A ASN 16 22.14 106.50 1 A SER 25 74.10 -64.96 1 A ASP 27 35.67 31.84 1 A CYS 33 -90.82 -149.63 1 A VAL 34 -161.78 -161.26 1 A ILE 35 -68.70 54.11 1 A SER 38 -157.56 -157.97 1 A ASP 40 -47.10 -98.03 1 A CYS 42 -172.96 31.73 1 A LEU 47 -56.97 72.50 1 A ARG 48 -145.33 -89.82 1 A TRP 49 -40.86 -80.14 1 A GLU 51 48.11 20.43 1 A LEU 52 63.63 -3.18 2 A SER 2 172.38 -16.23 2 A TYR 3 41.35 100.97 2 A PRO 7 -38.62 115.18 2 A SER 8 -38.60 -24.10 2 A SER 9 -52.45 -8.73 2 A TYR 10 -100.70 -74.69 2 A ASP 11 35.34 39.95 2 A ASN 16 49.02 103.23 2 A SER 25 -51.20 -74.69 2 A SER 28 -75.14 -162.69 2 A THR 30 -150.70 -151.11 2 A CYS 33 -58.05 -147.10 2 A ILE 35 -67.82 29.62 2 A SER 38 -165.94 -148.00 2 A ASP 40 -53.23 -100.80 2 A CYS 42 -172.04 22.67 2 A THR 44 -69.94 98.16 2 A LEU 47 -58.89 86.10 2 A ARG 48 -172.80 -92.20 2 A TRP 49 -23.89 -117.44 2 A TRP 50 34.04 108.76 2 A GLU 51 153.32 163.13 2 A LEU 52 55.77 140.71 3 A SER 2 -38.52 144.68 3 A PRO 7 -38.88 146.49 3 A SER 9 -47.42 -14.40 3 A ASN 16 11.23 106.14 3 A ASP 27 53.58 7.31 3 A SER 28 -76.36 -157.77 3 A CYS 33 -73.85 -144.53 3 A VAL 34 -164.94 -164.15 3 A ILE 35 -68.07 52.14 3 A ASP 40 -49.14 -99.13 3 A CYS 42 -173.22 30.83 3 A GLN 43 -69.29 28.68 3 A LEU 47 -57.65 100.48 3 A ARG 48 171.96 -73.61 3 A LEU 52 53.36 159.22 4 A SER 2 54.73 17.13 4 A TYR 3 37.47 107.62 4 A PRO 7 -38.59 114.31 4 A SER 8 -39.65 -24.52 4 A SER 9 -48.51 -17.75 4 A TYR 10 -83.84 -82.16 4 A ASP 11 32.05 28.94 4 A CYS 14 178.79 97.56 4 A ASN 16 25.29 103.62 4 A ASP 27 48.00 12.74 4 A SER 28 -77.50 -162.03 4 A CYS 33 -90.09 -149.74 4 A ILE 35 -69.25 57.58 4 A SER 38 -170.08 -159.84 4 A ASP 40 -44.91 -89.49 4 A CYS 42 -175.42 28.07 4 A LEU 47 -60.51 70.69 4 A ARG 48 -141.03 -93.08 4 A TRP 49 -39.29 -84.32 4 A TRP 50 -55.99 -70.21 4 A GLU 51 57.63 3.98 4 A LEU 52 52.78 171.50 5 A SER 2 168.62 -85.17 5 A TYR 3 51.48 106.44 5 A PRO 7 -37.70 154.03 5 A SER 9 -47.84 -17.28 5 A ASN 16 21.12 100.84 5 A SER 25 -41.39 -76.16 5 A ASP 27 50.38 10.34 5 A SER 28 -77.28 -168.05 5 A CYS 33 -58.76 -152.92 5 A VAL 34 -160.15 -162.94 5 A SER 38 -163.15 -166.56 5 A ASP 40 -49.31 -105.26 5 A CYS 42 -176.24 29.41 5 A LEU 47 -65.72 76.49 5 A ARG 48 -138.79 -87.57 5 A TRP 49 -39.59 -82.29 5 A TRP 50 -53.02 95.50 5 A LEU 52 -57.73 173.82 6 A SER 2 71.52 -18.08 6 A TYR 3 43.54 95.41 6 A PRO 4 -58.76 100.84 6 A PRO 7 -33.89 123.93 6 A SER 9 -46.72 -16.67 6 A TYR 10 -91.34 -87.01 6 A ASP 11 29.68 31.22 6 A ASN 16 31.79 100.23 6 A SER 25 75.13 -59.96 6 A CYS 33 -91.98 -149.96 6 A VAL 34 -164.18 -164.88 6 A ILE 35 -69.19 33.14 6 A SER 38 -166.72 -162.53 6 A ASP 40 -46.84 -90.17 6 A CYS 42 -172.77 37.26 6 A ASP 46 -44.38 -166.34 6 A ARG 48 -130.24 -78.70 6 A TRP 49 -27.23 -125.65 6 A TRP 50 5.59 84.25 7 A SER 2 53.50 5.85 7 A TYR 3 34.30 100.21 7 A PRO 7 -41.68 158.26 7 A SER 9 -46.92 -17.99 7 A TYR 10 -88.50 -79.19 7 A ASP 11 33.35 25.59 7 A ASN 16 8.53 103.44 7 A SER 25 -54.75 -75.49 7 A ASP 27 60.95 -0.66 7 A SER 28 -75.77 -158.86 7 A CYS 33 -69.57 -148.26 7 A VAL 34 -164.00 -166.82 7 A ILE 35 -66.15 58.74 7 A SER 38 -160.22 -149.63 7 A ASP 40 -62.95 -118.62 7 A CYS 42 -171.20 31.97 7 A GLN 43 -69.58 10.55 7 A LEU 47 -61.43 69.31 7 A ARG 48 -141.40 -80.36 7 A TRP 49 -42.23 -79.02 7 A GLU 51 -43.29 -93.93 8 A SER 2 75.70 -39.35 8 A TYR 3 46.19 108.58 8 A PRO 7 -38.44 114.67 8 A SER 9 -47.31 -17.65 8 A TYR 10 -81.98 -84.55 8 A ASP 11 28.05 35.10 8 A ASN 16 27.68 95.02 8 A SER 25 -43.04 -82.55 8 A CYS 33 -58.66 -161.46 8 A VAL 34 -161.92 -163.03 8 A SER 38 -161.60 -163.94 8 A ASP 40 -58.55 -111.93 8 A CYS 42 -170.71 39.35 8 A ARG 48 172.34 -72.70 8 A TRP 49 -35.07 -90.17 8 A TRP 50 -44.36 94.33 8 A GLU 51 -169.66 -84.36 8 A LEU 52 53.82 -73.05 9 A SER 2 175.84 -2.37 9 A TYR 3 35.19 101.98 9 A PRO 4 -56.82 107.49 9 A PRO 7 -33.14 142.29 9 A SER 9 -46.51 -17.73 9 A TYR 10 -91.25 -75.32 9 A ASP 11 35.95 23.40 9 A TYR 13 -138.86 -42.55 9 A SER 25 166.94 -86.82 9 A ASP 27 58.55 17.68 9 A SER 28 -78.39 -167.66 9 A CYS 33 -82.45 -145.76 9 A VAL 34 -161.96 -165.35 9 A ILE 35 -68.81 53.48 9 A SER 38 -161.38 -165.87 9 A ASP 40 -42.74 -89.12 9 A CYS 42 -177.35 73.74 9 A LEU 47 -62.40 72.28 9 A ARG 48 -143.63 -86.47 9 A TRP 49 -39.26 -72.78 9 A TRP 50 -59.85 -77.66 9 A GLU 51 58.42 177.58 10 A TYR 3 53.04 105.37 10 A PRO 7 -37.15 109.96 10 A SER 8 -39.18 -25.57 10 A TYR 10 -89.75 -70.27 10 A ASP 11 35.21 31.28 10 A ASN 16 37.86 87.33 10 A SER 25 -42.05 -81.43 10 A ASP 27 53.48 12.97 10 A SER 28 -76.50 -162.10 10 A CYS 33 -64.63 -152.57 10 A VAL 34 -160.73 -163.48 10 A SER 38 -161.24 -157.75 10 A ASP 40 -45.47 -97.36 10 A ARG 41 -77.60 -71.48 10 A CYS 42 -173.03 36.57 10 A LEU 47 -62.29 74.61 10 A ARG 48 -140.55 -81.45 10 A TRP 49 -47.67 -84.06 10 A GLU 51 -149.92 -73.65 10 A LEU 52 -33.93 115.36 model building X-PLOR refinement X-PLOR phasing X-PLOR EPIDERMAL GROWTH FACTOR (EGF) IN PH 2 SOLUTION (NMR, 10 STRUCTURES) THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS 1 Y N disulf 2.019 A CYS 6 A SG CYS 6 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.021 A CYS 14 A SG CYS 14 1_555 A CYS 31 A SG CYS 31 1_555 disulf 2.018 A CYS 33 A SG CYS 33 1_555 A CYS 42 A SG CYS 42 1_555 GROWTH FACTOR GROWTH FACTOR EGF_MOUSE UNP 1 1 P01132 MPWGRRPTWLLLAFLLVFLKISILSVTAWQTGNCQPGPLERSERSGTCAGPAPFLVFSQGKSISRIDPDGTNHQQLVVDA GISADMDIHYKKERLYWVDVERQVLLRVFLNGTGLEKVCNVERKVSGLAIDWIDDEVLWVDQQNGVITVTDMTGKNSRVL LSSLKHPSNIAVDPIERLMFWSSEVTGSLHRAHLKGVDVKTLLETGGISVLTLDVLDKRLFWVQDSGEGSHAYIHSCDYE GGSVRLIRHQARHSLSSMAFFGDRIFYSVLKSKAIWIANKHTGKDTVRINLHPSFVTPGKLMVVHPRAQPRTEDAAKDPD PELLKQRGRPCRFGLCERDPKSHSSACAEGYTLSRDRKYCEDVNECATQNHGCTLGCENTPGSYHCTCPTGFVLLPDGKQ CHELVSCPGNVSKCSHGCVLTSDGPRCICPAGSVLGRDGKTCTGCSSPDNGGCSQICLPLRPGSWECDCFPGYDLQSDRK SCAASGPQPLLLFANSQDIRHMHFDGTDYKVLLSRQMGMVFALDYDPVESKIYFAQTALKWIERANMDGSQRERLITEGV DTLEGLALDWIGRRIYWTDSGKSVVGGSDLSGKHHRIIIQERISRPRGIAVHPRARRLFWTDVGMSPRIESASLQGSDRV LIASSNLLEPSGITIDYLTDTLYWCDTKRSVIEMANLDGSKRRRLIQNDVGHPFSLAVFEDHLWVSDWAIPSVIRVNKRT GQNRVRLQGSMLKPSSLVVVHPLAKPGADPCLYRNGGCEHICQESLGTARCLCREGFVKAWDGKMCLPQDYPILSGENAD LSKEVTSLSNSTQAEVPDDDGTESSTLVAEIMVSGMNYEDDCGPGGCGSHARCVSDGETAECQCLKGFARDGNLCSDIDE CVLARSDCPSTSSRCINTEGGYVCRCSEGYEGDGISCFDIDECQRGAHNCAENAACTNTEGGYNCTCAGRPSSPGRSCPD STAPSLLGEDGHHLDRNSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELRHAGYGQKHDIM VVAVCMVALVLLLLLGMWGTYYYRTRKQLSNPPKNPCDEPSGSVSSSGPDSSSGAAVASCPQPWFVVLEKHQDPKNGSLP ADGTNGAVVDAGLSPSLQLGSVHLTSWRQKPHIDGMGTGQSCWIPPSSDRGPQEIEGNSHLPSYRPVGPEKLHSLQSANG SCHERAPDLPRQTEPVK 977 1029 1EPH 1 53 P01132 A 1 1 53 3 2 anti-parallel anti-parallel anti-parallel A SER 2 A SER 2 A PRO 4 A PRO 4 A VAL 19 A VAL 19 A ILE 23 A ILE 23 A SER 28 A SER 28 A ASN 32 A ASN 32 A TYR 37 A TYR 37 A SER 38 A SER 38 A THR 44 A THR 44 A ARG 45 A ARG 45 1 P 1